DAIVOBET 50mcg / 0.5mg / g gel medication leaflet

D05AX52 calcipotriol + betamethasone • Dermatologicals | Antipsoriatics for topical use | Other antipsoriatics for topical use

Calcipotriol and betamethasone are used together for the treatment of plaque psoriasis, a chronic skin condition characterized by red patches covered with whitish scales. This combination reduces inflammation, itching, and slows down the excessive growth of skin cells.

Calcipotriol is a vitamin D analog that helps normalize the cell regeneration process, while betamethasone is a potent corticosteroid that reduces inflammation and suppresses local immune reactions.

The treatment is applied topically, usually in the form of an ointment or gel, and is intended for short-term use to avoid corticosteroid-related side effects. It is important to avoid application on the face, skin folds, or areas with thin skin.

Side effects may include local irritation, burning sensation, or itching. Long-term use can lead to skin thinning or other corticosteroid-related complications.

General data about DAIVOBET 50mcg / 0.5mg / g

Substance: calcipotriol + betamethasone

Date of last drug list: 01-06-2025

Commercial code: W58498001

Concentration: 50mcg / 0.5mg / g

Pharmaceutical form: gel

Quantity: 1

Product type: original

Price: 42.91 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LEO PHARMA A/S - DANEMARCA

Holder: LEO PHARMA A/S - DANEMARCA

Number: 9001/2016/01

Shelf life: 2 years-after packing for marketing; after the first opening-3 months

Pharmaceutical forms available for calcipotriol + betamethasone

Concentrations available for calcipotriol + betamethasone

0.5mg/g, 50mcg/0.5mg/g

Other substances similar to calcipotriol + betamethasone

Compensation lists for DAIVOBET 50mcg / 0.5mg / g LEO PHARMA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

42.91 RON

20.94 RON

21.97 RON